From: Using second harmonic generation to predict patient outcome in solid tumors
Characteristics | No. patients (%) | Median levels (interquartile range) | p |
---|---|---|---|
All patients | 221 (100 %) | 2.228 (0.416) | |
Age (years) | 0.773a | ||
≤ 40 | 33 (14.9 %) | 2.160 (0.566) | |
41–55 | 94 (42.5 %) | 2.215 (0.410) | |
56–70 | 70 (31.7 %) | 2.291 (0.456) | |
> 70 | 24 (10.9 %) | 2.198 (0.327) | |
Menopausal status | 0.497b | ||
Premenopausal | 113 (51.1 %) | 2.200 (0.447) | |
Postmenopausal | 108 (48.9 %) | 2.250 (0.379) | |
Tumor size | 0.188a | ||
pT1 (≤2 cm) | 109 (49.3 %) | 2.239 (0.356) | |
pT2 (2–5 cm) | 105 (47.5 %) | 2.237 (0.505) | |
pT3/pT4 (>5 cm) | 7 (3.2 %) | 1.830 (0.614) | |
Tumor gradec | 0.700a | ||
I | 37 (16.7 %) | 2.207 (0.288) | |
II | 77 (34.8 %) | 2.233 (0.366) | |
III | 101 (45.7 %) | 2.264 (0.491) | |
ER status | <0.001b | ||
Positive | 125 (56.6 %) | 2.168 (0.407) | |
Negative | 96 (43.4 %) | 2.311 (0.452) | |
PgR status | 0.003b | ||
Positive | 104 (47.1 %) | 2.159 (0.392) | |
Negative | 117 (52.9 %) | 2.302 (0.425) | |
HER2 status | 0.121b | ||
Positive | 26 (11.8 %) | 2.299 (0.399) | |
Negative | 195 (88.2 %) | 2.215 (0.432) |